Product Program year 2025 Source: CMS Open Payments

Journavx

Drug Pain

NDC 51167-548-30

Open in the dashboard

General payments

$3,213,365

41,850 payments

Research payments

$0

0 payments

Through program year 2025, $3,213,365 in general payments and $0 in research payments were reported against Journavx (Pain).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $3,213,365 41,850

Breakdown

Who paid General payments · program year 2025
  1. Vertex Pharmaceuticals Incorporated $3,213,365 41,850 payments
Top recipients General payments · program year 2025
  1. Vinod Dasa Orthopaedic Surgery · Kenner, LA $91,723 3% · 90 payments
  2. Scott Sigman Orthopaedic Surgery · North Chelmsford, MA $82,556 3% · 74 payments
  3. Nirav Amin Orthopaedic Surgery · Placentia, CA $70,919 2% · 86 payments
  4. Raymond Hwang Orthopaedic Surgery of the Spine · Chestnut Hill, MA $60,272 2% · 63 payments
  5. Michael Bottros Anesthesiology · Los Angeles, CA $55,706 2% · 78 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $625,977 20% · 2,003 practitioners
  2. Anesthesiology $574,511 18% · 1,060 practitioners
  3. Pain Medicine Anesthesiology $205,748 6% · 680 practitioners
  4. Physician Assistant $159,440 5% · 3,425 practitioners
  5. Pain Medicine $152,137 5% · 223 practitioners

The top 5 of 198 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $558,918 17% · 2,226 recipients
  2. Florida $313,536 10% · 1,503 recipients
  3. Texas $306,432 10% · 3,034 recipients
  4. New York $259,960 8% · 1,558 recipients
  5. Massachusetts $235,679 7% · 376 recipients

The top 5 of 54 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

41,850 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record